Revision as of 21:13, 10 December 2012 editGigemag76 (talk | contribs)Extended confirmed users19,615 editsmNo edit summary← Previous edit | Revision as of 10:21, 29 January 2013 edit undoYobot (talk | contribs)Bots4,733,870 editsm →External links: clean up / fixed sortkey (checkwiki error #37 and #6) using AWB (8873)Next edit → | ||
Line 49: | Line 49: | ||
* (caduet.com) | * (caduet.com) | ||
{{DEFAULTSORT:Atorvastatin amlodipine}} | |||
] | ] | ||
] | ] |
Revision as of 10:21, 29 January 2013
Pharmaceutical compoundCombination of | |
---|---|
Amlodipine | Calcium channel blocker |
Atorvastatin | Statin |
Clinical data | |
Routes of administration | Oral |
ATC code | |
Legal status | |
Legal status |
|
Identifiers | |
PubChem CID | |
ChemSpider | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
3D model (JSmol) | |
SMILES
| |
InChI
| |
(verify) |
The drug combination atorvastatin/amlodipine (trade names Caduet in the US and Australia, and Envacar elsewhere) is a medication approved by the Food and Drug Administration (FDA) for the treatment of high cholesterol and high blood pressure. It is a fixed-dose combination drug containing the calcium channel blocker amlodipine and the statin atorvastatin being marketed by the pharmaceutical company Pfizer.
References
- "CADUET (amlodipine besylate/atorvastatin calcium) Tablets" (PDF). NDA 21-540/S-009. United States Food and Drug Administration. 2010. Retrieved 2010-09-25.
{{cite web}}
: Unknown parameter|month=
ignored (help)
External links
- Manufacturer's site (caduet.com)
This drug article relating to the cardiovascular system is a stub. You can help Misplaced Pages by expanding it. |